These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9794682)

  • 1. Opioid detoxification in pregnancy.
    Dashe JS; Jackson GL; Olscher DA; Zane EH; Wendel GD
    Obstet Gynecol; 1998 Nov; 92(5):854-8. PubMed ID: 9794682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital.
    Gopalan P; Moses-Kolko E; Valpey R; Shenai N; Smith E
    Gen Hosp Psychiatry; 2019; 57():29-33. PubMed ID: 30669023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between maternal methadone dosage and neonatal withdrawal.
    Dashe JS; Sheffield JS; Olscher DA; Todd SJ; Jackson GL; Wendel GD
    Obstet Gynecol; 2002 Dec; 100(6):1244-9. PubMed ID: 12468169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
    Day E; Strang J
    J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The obstetrical and neonatal impact of maternal opioid detoxification in pregnancy.
    Stewart RD; Nelson DB; Adhikari EH; McIntire DD; Roberts SW; Dashe JS; Sheffield JS
    Am J Obstet Gynecol; 2013 Sep; 209(3):267.e1-5. PubMed ID: 23727040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal interventions based upon fetal surveillance of the daily opioid-exposed fetus: a descriptive analysis.
    Brar B; Jackson D; Nat M; Patil P; Iriye B; Planinic P
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):909-912. PubMed ID: 30078349
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioids affect the fetal brain: reframing the detoxification debate.
    Caritis SN; Panigrahy A
    Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: a blind inpatient study.
    Uhde TW; Redmond DE; Kleber HD
    Psychiatry Res; 1980 Mar; 2(1):37-47. PubMed ID: 6932053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns.
    Kienbaum P; Scherbaum N; Thürauf N; Michel MC; Gastpar M; Peters J
    Crit Care Med; 2000 Apr; 28(4):969-76. PubMed ID: 10809268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
    Oliveros SC; Caballero L; Iruela LM
    Med Clin (Barc); 1990 Nov; 95(16):627-9. PubMed ID: 2097456
    [No Abstract]   [Full Text] [Related]  

  • 15. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine in outpatient detoxification from methadone maintenance.
    Kleber HD; Riordan CE; Rounsaville B; Kosten T; Charney D; Gaspari J; Hogan I; O'Connor C
    Arch Gen Psychiatry; 1985 Apr; 42(4):391-4. PubMed ID: 3977557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
    Kleber HD
    Dialogues Clin Neurosci; 2007; 9(4):455-70. PubMed ID: 18286804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.
    Sees KL; Delucchi KL; Masson C; Rosen A; Clark HW; Robillard H; Banys P; Hall SM
    JAMA; 2000 Mar; 283(10):1303-10. PubMed ID: 10714729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone.
    Howells C; Allen S; Gupta J; Stillwell G; Marsden J; Farrell M
    Drug Alcohol Depend; 2002 Jul; 67(2):169-76. PubMed ID: 12095666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.